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ABSTRACT 
In 2015, the Cystic Fibrosis (CF) Foundation collaborated with the European CF 
Society to develop new guidelines to screen for depression and anxiety in people with 
CF. The guidelines were based on a study that assessed over 6,000 patients and 4,000 
caregivers among 45 centers in the United States and eight European countries. Research 
has proven that depression and anxiety have a negative impact on CF and overall health. 
186 adolescents within the CF clinic at Children’s Health Center voluntarily completed 
the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7). 
These screenings were completed between February 2016-March 2017 and the data was 
stored within an Excel Workbook. The existing data was then used for this study. Chart 
reviews were conducted on each of the patients to obtain the number of hospitalizations 
and length of stay as well as patient’s gender. Statistical Package for the Social Sciences 
(SPSS) was used to analyze the correlation, if any, between depressive and anxious 
symptoms and hospitalizations or length of stay. A significant correlation was found 
between depression symptoms and gender (p<0.05). Females were significantly more 
likely to report depression symptoms compared to their male counterparts (p<0.05). 
Based on literature, adolescent males are less likely to report mental health symptoms. 
Further research needs to be completed to address the male population in regards to being 
open about addressing their mental health status. More research needs to be completed on 
mental health symptoms related to overall quality of life. 
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CHAPTER I 
INTRODUCTION
In 1938, Dorothy Anderson was the first person to recognize the symptoms of 
Cystic Fibrosis (CF) and helped create a way to test and diagnose the disease. Over time, 
it was determined to be a genetic disorder that requires time-consuming medical 
interventions. CF is characterized by lack of growth, pulmonary infections, and the 
absence of pancreatic enzyme secretion, which leads to nutritional failure (Cohen-
Cymberknoh et al., 2006). It creates thick, sticky mucus within the lungs that adheres to 
airway surfaces (Cohen-Cymberknoh et al., 2006). The physical symptoms associated 
with CF may have implications for daily life, but the presence of depression and anxiety 
symptoms has also been found to impair daily functioning for adolescents – specifically 
in areas like socialization (Pinquart & Shen, 2010). During adolescence, biological, 
psychological, and sociological changes are occurring. Thought processes and cognitive 
abilities are maturing and growing. CF can interrupt these processes because it has the 
potential to delay puberty up to two years, which can result in stunted growth (Segal, 
2008). Children during this stage are beginning to grasp the concept of a cause and effect 
relationship for any action made (Segal, 2008). They are still maturing to the point of 
being able to see the consequences for their actions, which is why management strategies 
for CF should be stressed (Segal, 2008).  
Adolescents need accurate and consistent support while coping with a chronic 
illness because it may affect many areas of development. CF requires rigorous 
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maintenance and time in order to have a higher quality of life (Cystic Fibrosis 
Foundation, n.d.). For instance, patients may have to do airway clearance techniques 
(ACTs) such as coughing, in order to loosen the mucus in their lungs (Cystic Fibrosis 
Foundation, n.d.). CF patients also take enzymes due to the nutritional failure and other 
medication such as nebulizer treatments, in order to fight infections (Cystic Fibrosis 
Foundation, n.d.). These treatments can require long periods of time in order to complete 
them. It is important to know how this affects family functioning, treatment adherence, 
and mental health of this population. Research has shown that people with CF are at a 
higher risk of developing symptoms of depression and anxiety (Quittner et al., 2014). The 
presence of depression and anxiety are two to three times higher among adolescents with 
CF than the general population (Quittner et al., 2014), and may interfere with the ability 
of adolescents and parents to maintain adherence. Given this bi-directional relationship 
between physical and mental health among patients with CF (Knudsen et al., 2016), it is 
hypothesized that patients who report having higher symptoms of depression and anxiety 
will also have a higher rate of hospitalization.  
In 2015, the CF Foundation collaborated with the European CF Society to 
establish new guidelines to address the mental health aspect of the CF centers (CF 
Foundation, 2015). These guidelines include screening patients 12 to 17 years of age 
annually using the self-reported assessment which include the Patient Health 
Questionnaire (PHQ-9) and the Generalized Anxiety Disorder 7 (GAD-7). These told are 
designed to screen for depression or anxiety symptoms within the patient. Given past 
research and the mental health symptoms associated with CF, the purpose of this study is 
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to determine how depression and anxiety symptoms correlate with hospitalizations 
among adolescent patients with CF.
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CHAPTER II 
LITERATURE REVIEW
Family Functioning 
The way in which families are first told about a diagnosis is extremely important. 
When a parent is told that their child has a chronic life-threatening illness, it may result in 
a range of emotions. Caregivers may remember the day, location, how the information 
was given, and who told them. When a child is first diagnosed with CF, families may go 
through confusion, disbelief, anxiety, turmoil, and a loss of identity (Smith, Cheater, & 
Bekker, 2013). For some parents, the new information can potentially make it difficult to 
retain information and feelings of self=blame may begin (Smith et al., 2013).  
Although it is difficult to receive a report of a new diagnosis, it is important for 
families to develop a routine as soon as treatments begin. This is to help families plan and 
organize their time so that they can maintain treatments and prioritize other necessities 
throughout their day (Grossoehme, 2014). By developing time management skills, the 
burden of treatment regimens may decrease (Grossoehme, 2014). It is acknowledged that 
developing a routine can be difficult especially for first time parents.  
Once told of a new diagnosis, families may think immediately about the future 
and how it will look. This in turn may cause feelings of anxiety to arise. It is important to 
stress to caregivers how important it is to be open about how they are feeling so that they 
can develop healthy habits of open communication early on. For instance, as a child with 
a chronic illness begins to grow older, parents feel a sense of guilt for using respite 
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services in order to take time for self-care, therefore they will not speak out about the 
need for this service. By allowing concerns and frustrations to build, separation of the 
caregivers can potentially increase (Douglas et al., 2015; Heywood, 2010 & McCoyd et 
al., n.d.). Therefore, emphasizing to parents the option for respite services is important to 
decrease high statistics of separation and improve or maintain their overall quality of life 
(Burton, 2008). If parents or caregivers are able to develop a habit of speaking about 
emotions, then resources can be available to help manage and cope with these emotions. 
This allows parents to tend to their own relationship so that the fear of separation 
diminishes (McCoyd et al., n.d.).  
Findings show that a child with a chronic diagnosis can have the opposite effect 
on families. Some families state that their child’s diagnosis brought them closer (McCoyd 
et al., n.d.). This could be caused by a common want to advocate and provide consistent 
help for their child. It appears that when both partners are actively involved in the child’s 
care, the divorce rates are lowered (McCoyd et al., n.d.). Another positive result to equal 
involvement in care is the decreased likelihood of developing relationship strain between 
parent and child (Grossoehme, 2014). If there is a higher involvement emotionally 
between parent and child, this can result in higher reinforcement rates for treatments 
(Grossoehme, 2014). This in turn results in less child-parent conflict because the child 
can be actively involved in their care routines (Grossoehme, 2014). It is also known that 
becoming adapted to a child’s illness is difficult and will take for families due to the 
consistent change that is occurring (Smith et al., 2013). Constant change can cause burn 
out in families both physically and mentally.  
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Chronic illnesses have shown to be a factor that promotes stress among families 
in general. Mothers felt stress from fear of being the main caretaker and fathers were 
stressed from the perception of maintaining the family provider role (Smoth et al., 2013). 
Approximately sixteen percent of mothers with children that have a chronic illness or 
disability are able to work compared to the sixty one percent of mothers that do not have 
a child with these concerns (Heywood, 2010). This ultimately results in lower family 
incomes, which limits a child’s resources (Heywood, 2010). This can be a major stressor 
for parents and caregivers.  
Parental stress has shown to be a risk factor among adolescents and their siblings 
(O’Haver et al., 2010). Parental stress and lack of social support has been linked to poor 
adaptation among the health siblings (O’Haver et al., 2010). This could be attributed to 
inconsistent family routines, lack of resources to help adjust to a new situation, or how 
the healthy siblings (O’Haver et al., 2010). This could be attributed to inconsistent family 
routines, lack of resources to help adjust to a new situation, or how the healthy sibling 
views the diagnosis and its (Everhart et al., 2014) impact on daily living. Siblings of 
adolescents with a chronic illness are at a greater risk to develop emotional and 
behavioral problems, which can be attributed to the parents prioritizing their time with 
the child that has the illness (Heywood, 2010). As a result, the siblings can have lower 
self-esteem, academic performance, and behavior and emotional delays (Heywood, 
2010).  
CF impacts treatment and personal care regimens, social and financial aspects, 
and relationships, which may disrupt how the family functions altogether. The treatment 
regimens required by CF take long periods of time and commitment. Many families have 
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to wake up extremely early in order to help their child with breathing treatments. 
Furthermore, families tend to rely more on being task oriented rather than addressing the 
emotional or interactional pieces of their life due to the treatment regimens required by 
CF (Everhart, Fiese, Smyth, Borschuk, & Anbar, 2014). Therefore, identifying factors 
that impact a child and their family’s quality of life is important for their overall health.  
Financial concerns may be another source of stress for families coping with a 
chronic illness. Evidence shows that finances had a negative impact on parental 
relationships (O’Haver et al., 2010). Families with a child that has a disability have 
financial costs that are up to three times higher than families that are not raising a child 
with an illness or disability (O’Haver et al., 2010). With this high statistic it can be 
assumed that stress will potentially be associated with it. The stress and concern of 
finances negatively affect the adolescent’s adaptation as well (O’Haver et al., 2010). It is 
important to note the evidence that suggests chronic illnesses do not impact a child’s 
daily living or socialization (Denny et al., 2013 & Higham et al., 2013). This could be 
directly related to age, situation, or other outside factors.  
Treatment Adherence 
Family functioning significantly impacts treatment adherence because it is 
directly related to psychological functioning of the adolescent. Adhering to treatment 
regimens can be difficult at times due to the changes that are taking place during 
adolescence paired with a chronic illness. The research shows that the average rate of 
treatment adherence is at or below fifty percent, specifically in the CF population (Modi 
et al., 2006). Treatment adherence can only be maintained if the resources are available. 
The lack of resources needed for medications and equipment have also been shown to be 
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a stressor among families. If a family cannot afford medications or equipment, treatment 
adherence significantly decreases.  
Not adhering to treatments can have a range of negative effects. Some of these 
include: increased morbidity and mortality, lower quality of life, and increased healthcare 
costs. Adhering to treatments can be difficult when a family does not fully understand the 
treatment process, forgets the side effects of not adhering, or lacks the resources to be 
able to maintain treatment regimens (Hanghoj et al., 2014; Modi & Quittner, 2006). If a 
family lacks the resources to be able to maintain the treatment regimen, the overall 
quality of life of the patient will significantly decrease. Lower socioeconomic (SES) 
families may have worse outcomes in their child (Barr et al., 2011; Douglas et al., 2015; 
O’Connor et al., 2003 & Schechter et al., 2001).  
Although there are many financial needs for families, the good news is that there 
are many programs and organizations that provide assistance by meeting specific criteria. 
For example, Medicaid waiver programs help with medications, medical devices, home 
modifications, or specific therapies. Financial assistance programs such as Supplemental 
Security Income (SSI), Temporary Assistance to Needy Families (TANF), Supplemental 
Nutrition Assistance Program (SNAP), and public housing are available. There is the 
down side of availability, wait lists, and long application processes (Reichman, Corman, 
& Noonan, 2998).  
CF can disrupt social development, which can make it increasingly difficult to 
maintain and manage their treatments due to the stigma placed on chronic illnesses. 
Treatment regimens for CF patients are intense and complex, which can make it difficult 
to remain consistent. It is important to teach adolescents healthy and consistent behaviors 
9 
 
 
 
for treatment so that they are prepared for transition into adult care. Teaching adolescents 
healthy behaviors can have the most effective impact if the adolescent understands CF in 
its entirety. A 2009 study was completed and thirteen of adolescents reported that they do 
not believe they will have CF for the rest of their lives (Bucks et al., 2009). Therefore, 
incorporating more education for adolescents with CF and their families can potentially 
increase the levels of adherence throughout this population.  
This is why it is important to maintain a healthy patient-provider relationship. 
Providers can offer guidance to the family and adolescent to explain CF and what it 
requires to have a higher quality of life. The psychosocial team can encourage attendance 
to clinic visits, which can improve the adolescent’s knowledge of their disease. By doing 
this, rates of adherence may increase (Kazmerski et al., 2015). However, it is important to 
note that increased knowledge does not necessarily produce an improved health status. It 
does increase the ability of adolescents to learn self-management (Kazmerski et al., 
2015).  
Adults with CF have reported that clinic visits have held them accountable for 
their adherence to treatment. Addressing non-adherence is important to identifying 
barriers that are causing it. However, a study showed that thirty-five percent of centers do 
not address adherence consistently (Riekert, 2015). By not addressing these concerns, 
there are missed opportunities to support the family and to offer resources that can 
increase their adherence.  
Some parents and young adults believe that medications are unnecessary and are 
not benefiting their health (Hanghoj et al., 2014). Side effects of medications and 
managing treatments at school have been proven to be barriers as well (Hanghoj et al., 
10 
 
 
 
2014). Physical symptoms and stigma have been reported to decrease the desire to 
maintain treatments (Hanghoj et al., 2014). There is also the issue of purposeful non-
compliance. Adolescents can potentially underestimate how CF affects them. 
Adolescents may either forget or state they feel fine without the need for treatment. Non-
compliance is also associated with patients not wanting to take medications or treatments 
in front of their peers for feat of embarrassment (Dodd, 2000). This is another reason that 
the need for increased knowledge on their disease is important for improved quality of 
life.  
Not only do adolescents need an increase in knowledge about their disease, they 
also need training when it comes to transition into adult care. Transitions may cause some 
anxious feelings because adolescents may feel their resources will be less accessible (Al-
Yateem, 2013). Therefore, educating them on this topic may decrease some of these 
concerns.  
Transition into Adult Care 
Lack of knowledge may affect the patient physically, but it can also affect them 
when the time comes to transition into adult healthcare. Consistent literature suggests that 
many patients with CF are concerned about transition and are not being adequately 
informed on the transition process (Al-Yateem, 2012; Kreindler & Miller, 2013; & 
Nazareth & Walshaw, 2013). Patients in a pediatric setting rely on parents or caretakers 
to assist in the process of treatments, clinic appointments, and other daily living tasks. 
When transition occurs, it is assumed that the patient is autonomous and can 
appropriately make their personal healthcare decisions (Nazareth & Walshaw, 2013).  
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One of the main areas of concerns for the pediatric patients is the late start to the 
introduction of transition. This affects the support, decision-making, and preparation 
proess for the young adults (Al-Yateem, 2012). Patients become increasingly anxious 
about the thought of making independent healthcare decisions and being able to manage 
their care effectively (Nazareth & Walshaw, 2013). Therefore, it is important to educate 
the parents and patient on the transition process and expectations. By addressing these 
concerns early on, patients and their families can work on preparing themselves for the 
transition. 
The literature suggests that there is a lack of standardized transition models for 
patients with CF (Al-Yateem, 2012 & Kreindler & Miller, 2013). However, there are 
processes and considerations that should be acknowledged prior to transition. For 
instance, a few characteristics of young adults that are important to note in order to guide 
the transition process are: readiness, age, knowledge level, and skills (Kreindler & Miller, 
2013). There are many families who advocate for their children during the process of 
transition. A few recommendations provided by families and patients in terms of family-
centered assessments are: talk about transition at an early age, explore the challenges by 
providing resources, and inform the patient on when, how and who will be a part of the 
transition process (Schlucter, 2014). Further implications should be: allow the patients 
and families to be involved in the decisions being made, encourage adolescents to be 
engaged in the decision-making, inform adult care providers of the former pediatric 
patient, and make sure that the providers and families are in agreement of the decisions 
being made (Schlucter, 2014). It is important to remember that transitions mean the 
12 
 
 
 
adolescent will lose relationships and will move to a place that is uncomfortable for some 
time (Schlicter, 2014).  
From the patient’s perspectives they had an overall negative feeling towards 
transition because they were unsure of the process and how it works (Garvey et al., 
2012). Their barriers to transition included: lack of a structured plan (Bhaumil et al., 
2011). Parents reported feeling more stressed and anxious compared to the patient 
because they were concerned about the future and the ability to receive adult care 
services (Kingsnorth, Gall, Beavni & Rigby, 2011). One study found that adult healthcare 
providers perceived pediatrics as overprotective and pediatrics saw adult care as uncaring 
(Zhou et al., 2016). Therefore, there needs to be early education for families and effective 
communication between providers to ensure the transition process is satisfactory. 
There is a lack of research on effective readiness models and instruments. A 
systematic review was conducted to assess the transition readiness tools (Stinson et al., 
2013). There are two assessment questionnaires that have been recommended for the 
transition process. The Transition Readiness Assessment Questionnaire (TRAQ) and the 
Social-Ecological Model of Adolescent and Young Adult Readiness to Transition 
(SMART) are two tools that assess the adolescent in areas of motivation, maturity, 
expectations, and readiness (Schwartz et al., 2013 & Zhang et al., 2014). These tools give 
the clinic team an indication that the adolescent is ready for the process or if they need to 
be transitioned at a later time.  
A 2013 study evaluated the patient’s experience post-transition (Chaudhary et al., 
2013). The study concluded that patients appreciated a structured program that also 
integrated the importance of autonomy prior to transition. Patients reported that their 
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access to adult services after transition was a barrier due to the lack of resources available 
to them (Bhaumik et al., 2011). More research needs to be conducted on the process of 
transition and how to prepare adolescents appropriately. 
Mental Health 
When addressing the topic of mental health it is important to note that there are 
many studies that contradict each other. For instance, some studies suggest that there is a 
lower quality of life and higher levels of mental health concerns among adolescents while 
other studies report that mental health outcomes are in line with healthy adolescents 
(Platten, 2012; Quittner et al., 2008 & Szyndler et al., 2005). Stress from chronic illness 
has shown to have an impact on a child’s mental health. Even with the medical advances 
that have increased life expectancy, there is still a substantial decrease in life satisfaction 
(Besier, 2012). For example, strong signs of depression and anxiety have been associated 
with CF and have contributed to a lower satisfaction of life (Arrington-Sander et al., 
2006; Besier, 2012 & Platten, 2013).  
There is also evidence that suggests adolescents function as well as their healthy 
peers. Interestingly, a study showed that adolescents with CF are less likely to develop 
mental health issues compared to their healthy peers (Szyndler et al., 2005). Reasons for 
this include: less significant burdens than in previous years and family support (Szyndler 
et al., 2005). Because of early diagnosis parents have time to cope and will be offered and 
services in a timely manner.  
It is still important for adolescents to maintain peer relationships. Chronic 
illnesses have the potential to separate an adolescent from their peers during the same 
time support is needed the most. Social support is important due to the increase in levels 
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of satisfaction, which ultimately improves the quality of life. Adolescents report that they 
receive most of their relational support from their peers and treatment support from their 
family members (Barker et al., 2011). Although adolescents recognized that the support 
was needed, there were still days when the constant questions about treatments and how 
they were feeling started to become annoying (Barker et al., 2011). A study showed that 
living in a partnership, regardless of gender, is directly related to satisfaction of life. If the 
person is surrounded by support and partnership their quality of life should increase. 
Even though the constant reminder of their disease can be monotonous and annoying; the 
support from family members and peers is still needed in order to improve their overall 
quality of life (Barker et al., 2011). 
Peer support groups are one way to integrate support for the adolescent. It is 
important to note that due to specific infection control policies, CF patients cannot be 
near each other. This poses some issues for support groups to be held. However, online 
groups have been shown to have positive outcomes on CF patients (Kirk & Milnes, 
2016). These support groups encourage participants to be open about their disease and it 
provides a safe space for parents and patients to express their emotions, concerns and to 
develop healthy coping styles (Kirk & Milnes, 2006). 
For female adolescents the coping style is generally denial, whereas males are 
more likely to engage in avoidant coping styles (Arrington-Sanders et al., 2006). 
However, CF does not only affect a child’s coping style; it also targets the parents’ 
coping style as well. It is important to take the parents’ mental health status into account 
when working with adolescents because of how influential these roles are on the young 
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patient. When attending to a child that has a chronic illness it can be hard to find time to 
cope with the diagnosis.  
A study found that there are two predominant coping styles that parents utilized. 
One style was proactive and the other was avoidant (Pfeffer et al., 2003 & Sheehan et al., 
2014). Proactive parents were involved, had optimistic perspectives and planned for 
treatments well whereas avoidant parents used passive and internalizing behaviors 
(Sheehan et al., 2014). Furthermore, parents are usually unaware that they are carriers of 
the gene before they conceive a child, therefore it can potentially cause them to feel as 
though they are at fault. When assessing different types of coping strategies, the most 
frequent topic is self-blame (Heywood, 2010 & Sheehan et al., 2014).  
Avoidant parents were distracted, abused substances, and blamed themselves for 
their child’s illness (Sheehan et al., 2014). Compared to proactive coping styles; avoidant 
parents reported more problematic child behaviors at mealtimes (Sheehan et al., 2014). 
The result, adolescents were keeping concerns and problems inside rather than speaking 
out effectively (Pfeffer et al., 2003 & Sheehan et al., 2014). This suggests that coping 
styles have an impact on a child’s behavior and quality of life (Pfeffer et al., 2003). Those 
who cope with avoidance are generally non-compliant and less adherent to treatment 
regimens (Pfeffer et al., 2003).  
In contrast, a study showed that adolescents voiced concern about their future. 
Their fears were about the intense suffering they felt they would go through due to their 
disease (Riekert et al., 2015). It is important that this population has psychosocial support 
available to them to maintain healthy coping skills. As a psychosocial team, it is 
important to advocate for the adolescent. For example, ensuring that the patient is seen 
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individually from time to time is important so the child can voice concerns without the 
fear of their parents being in the room.  
The CF Foundation is now requiring mental health screenings to be completed by 
all patients with CF that are 12 to 17 (Abbott et al., 2015). This allows the psychosocial 
team to assess for signs of mental health concerns early on rather seeing a patient that has 
been impacted severely without anyone knowing (Abbott et al., 2015). Not only does this 
help catch signs early, it will also help towards future advances for medical care. The CF 
Foundation and community can assess the needs of the patients based on the results of the 
screenings (Abbott et al., 2015). This may lead to more positive mental health outcomes 
and a focus on risk factors with mental health concerns. 
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CHAPTER III 
METHODOLOGY
Children’s CF clinic gathered data from completed mental health screenings with 
186 patients between February 2016 – March 2017. Administration of these screenings is 
considered standard of care for pediatric patients with CF. This study utilized secondary 
data from these mental health screenings and data available through chart reviews in the 
patient’s electronic medical record (EPIC). The study team gathered information 
regarding the frequency of hospitalizations from February 2016 – March 2017, length of 
stay, gender, and age. The study then aimed to identify any correlations between the 
depression and anxiety symptoms reported by patients and frequency of hospitalizations.  
Setting 
Appropriate International Review Board (IRB) approval was obtained (see 
Appendix A) from Children’s Medical Center and an affiliation agreement was signed by 
the IRB at Abilene Christian University (see Appendix B). The study is continuing to be 
researched in the CF clinic at Children’s Health Specialty Center in Dallas, Texas. The 
CF clinic manages outpatient and inpatient care for approximately 400 infants, children, 
and adolescents. During a patient’s visit they meet with providers, nurses, clinical 
educator, clinical dietician, social workers, medical assistants, respiratory therapists, 
research coordinators, and the clinic schedulers.  
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Sample 
Inclusion criteria consisted of patients with CF over the age of 12 who were either 
English or Spanish speaking. As standard of care, verbal consent was given prior to 
administration of the questionnaires. Based on the guidelines established by the  
CF Foundation, the mental health screenings were only administered to patients with CF 
ages twelve and older who voluntarily agreed to take the self-administered assessment. 
Patients with cognitive impairments, identified either by parent report or standard 
psychosocial assessment completed by the mental health team, did not complete the self-
report measures specifically associated with this study, therefore data collected from 
adolescents with cognitive impairments was excluded.  
Procedure 
As per IRB approval, verbal consent was obtained prior to the screening. The 186 
mental health screenings completed between February 2016 – March 2017 have been 
scored. De-identified data from the completed mental health screenings was already 
stored in a password protected excel file on the CF team’s shared drive. The code key 
was kept in a separate, password protected excel file on the shared drive. Both files were 
accessible only to study personnel. Chart reviews were then conducted for all patients 
who participated in the mental health screenings as part of the implementation of the CF 
guidelines. The mental health screening data that was collected was designed for Quality 
Improvement (QI) as standard of care in the CF clinic. Mental health screening data was 
de-identified and each patient’s data was assigned a unique identifier. The code key 
included the patient’s name, date of birth, and gender and it was stored in a password 
protected excel Workbook. The de-identified data from the mental health screenings and 
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medical records review was stored in a separate password protected excel workbook. 
Both workbooks had protection for read and write access, therefore only those with the 
password were able to view or edit the information. These excel workbooks were stored 
on the CF shared drive within Children’s database system. The Practice Administrator for 
the CF clinic was the only person authorized to provide access to this shared drive. 
Passwords for the Excel workbooks were only shared with members of the research team.  
Materials 
Two mental health questionnaires were administered to patients with CF that were 
twelve years old and older based on the CF Foundation guidelines established in 2015. 
The first questionnaire used in this study was the Patient Health Questionnaire (PHQ-9) 
(see Appendix C). This screening was developed by Robert L. Spitzer, MD. Kurt Kronke, 
MD, and Janet B. W. Williams, DSW. This is a nine question, self-administered 
instrument that scores eacg of the nine Diagnostic and Statistical Manual of Mental 
Disorders, 4th Edition (DSM-IV) criteria (0 = not at all, 1 = several days, 2 = more than 
half the days, 3 = nearly every day). Two studies were conducted to increase the validity 
of this instrument. The first study involved 3,000 patients in eight primary care clinics 
and the second study included 3,000 patients in seven obstetrics-gynecology clinics 
(Kroenke, Spitzer, & Williams, 2001). The PHQ-9 is substantially shorter than most 
depression measures and is based upon nine criteria that are used for the depression 
diagnosis within the DSM-IV. When the PHQ-9 is scored and the scores appear to be 
high; this allows for questions to be asked to officially determine depressive diagnoses 
based on the DSM-IV criteria and assess the symptom severity (Kroenke, et al., 2001). 
The scores are assigned to categories of mild, moderate, moderately severe, and severe 
20 
 
 
 
depression (scores of 5, 10, 15, and 20 respectively). When a patient scores 5-9 the 
treatment recommendation is to support and educate the patient on depression, 10-14 
should be treated with support, watchful waiting, or possible psychotherapy, 15-19 
should be treated with antidepressants or psychotherapy, and 20 or higher should also be 
treated with antidepressants or psychotherapy (Kroenke et al., 2001).  
The second instrument used for this study was the Generalized Anxiety Disorder 
self-report scale (GAD-7) (see Appendix D). A criterion-standard study consisting of 
2,740 participants was conducted in fifteen primary care clinics from November 2004 
through June 2005. To increase validity of this assessment, the GAD-7 reports were 
compared to independent diagnoses from mental health professionals (Spitzer, Kroenke, 
Williams, & Lowe, 2006). The self-report scale includes seven questions about feelings 
of anxiousness and worry over the last two weeks. The instrument is then scored (0 = not 
at all sure, 1 = several days, 2 = over half the days, 3 = nearly every day). The results are 
then assigned to mild, moderate, or severe anxiety (scores of 5, 10, and 15 respectively). 
Further evaluation of the patient is recommended when the score is 10 or above.  
After the clinic social worker or psychologist scored the questionnaires the patient 
was referred appropriately based on the results. There was no cost to the subjects and no 
payment for participation in this study. The mental health screenings are a guideline 
established by the CF Foundation.  
Analyses 
The results from the PHQ-9 and GAD-7, hospitalizations, length of stay, gender, 
and age were collected by the Master Social Work candidate and analyzed with 
assistance from Intern Supervisor, Bonnie Jenkins, LCSW, and Clinic Psychologist, 
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Jamie Becker, PhD for this study. This study required unique identifiers of participants’ 
scores and information. The latest version of SPSS was used for analyzing the data under 
the supervision of thesis chair, Dr. Wayne Paris, Intern Supervisor, Bonnie Jenkins, 
LCSW, and Clinic Psychologist Jaime Becker, PhD.
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CHAPTER IV 
RESULTS
Existing data from 186 patients was collected for this study. All of the patients 
were diagnosed with Cystic Fibrosis and ranged in age from 12 to 17 years (data not 
shown). The mean age of the patients was 15 years. There was a near equal distribution 
of males to females (n=45 and 42, respectively). 
Table 1  
T-Test Comparison Between PHQ-9 Scores and Gender 
	 Mean Scores Significance 
Male 3.44 P<0.05 
 
Female 
 
5.10 
 
P<0.05 
 
A t-test was run to determine the comparison between gender and the mean 
average of the PHQ-9 scores (see Table 1). The results showed that females were 
significantly more likely to possess depressive symptoms compared to their male 
counterparts (see Table 1). 
Table 2  
T-Test Comparison Between GAD-7 Scores and Gender 
	 Mean Scores Significance 
 
Male  
 
3.13 
 
NS 
 
Female 
 
6.81 
 
NS 
 
23 
 
The same test was run to determine if there was a difference between gender and 
the mean average of the GAD-7 scores. The results showed that there was no significant 
difference between GAD-7 scores with relation to gender (see Table 2). Further analyses 
compared gender by number of hospitalizations and mean length of stay. No statistical 
significance was found (data not shown). 
Table 3  
 
ANOVA Comparison of Hospitalizations, Average Length of Stay, and Screening Scores 
 
	 Hospitalizations Length of Stay Significance 
 
PHQ-9 
 
8.899  
 
.022 
 
NS 
 
GAD-7 
 
.574 
 
.259 
 
NS 
 
To determine if the severity of depression and anxiety were associated with 
hospitalizations and average length of stay one ANOVA was completed. This required 
recoding of the PHQ-9 and GAD-7 into their respective ratings for depression and 
anxiety. The ANOVA did not indicate any statistical significance associated with 
hospitalizations and length of stay in relation to the level of depression and anxiety (see 
Table 3). Finally, there was no significant difference in the number of hospitalizations 
and mean length of stay in relation to the severity of the GAD-7 and PH-9 scores and 
gender (data not shown). 
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CHAPTER V 
DISCUSSION
Research has shown CF, or any chronic illness, is a risk factor for depression and 
anxiety. The CF guidelines include four area of mental health care: prevention, screening, 
clinical assessment, and intervention. By screening children with CF, care centers across 
the world can begin improving their centers by incorporating the mental health care 
aspect into their clinic.  
The guidelines were established based on a study that assessed over 6,000 patients 
and 4,000 caregivers among 45 centers in the United States and eight European countries 
(Quittner et al., 2014). Research has proven that depression and anxiety have a negative 
impact on CF and overall health. The purpose of this thesis was to determine how 
depression and anxiety symptoms were associated to hospitalizations among adolescent 
patients with CF. The findings were consistent in some ways to the existing literature. A 
review of this information will follow, however, the limitations imposed on this work by 
the use of existing data must first be discussed.  
Ideally, the research team would have included additional demographic data for 
analyses. The ability to do so was restricted by what was available in the existing data. 
The data included gender, age, screening scores, and referrals made. This study could be 
expanded to include severity of the disease, payer status, ethnicity, and region. The 
reason for this is because each of these areas has shown to have an impact on CF and a 
person’s overall health. 
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Stroupe and colleagues conducted a study to compare insured and uninsured 
patients to determine if there was an effect on overall health (Stroupe et al., 2000). The 
results showed that the “presence of a chronic illness decreased the probability of having 
adequate coverage by about 10 percent among all individuals and by about 25 percent 
among single individuals (Stroupe et al., 2000, p.16).” Knowing what the payer status 
was at the time and how that correlates with overall health and hospitalizations would 
have been important to note. As the severity of the disease increases, the cost of 
management significantly increases as well. This is due to increase in medications, 
hospitalizations and possible travel expenses (Stroupe et al., 2000). 
Although there were limitations, there are significant findings to note. This study 
found that females are more likely to report depressive symptoms compared to their male 
counterparts. This could be related to the previous literature that discusses how females 
are more willing to discuss their mental health status. There was no significant 
relationship in anxious symptoms related to gender, which is not in line with the 
literature. Literature is consistently providing that depressive and anxious symptoms are 
more prevalent in females. There was also no significant correlation between mental 
health symptoms and hospitalizations. This is of interest to note because literature has 
provided evidence that shows mental illnesses such as depression and anxiety effect 
overall health. Bennett’s Meta-Analytic Review of 60 studies suggests that children 
diagnosed with a chronic disease are more likely to possess depressive symptoms 
compared to their physically healthy peers (Bennett, 1994). Therefore, it is important to 
note the time allowed for this study and the sample size. These factors could be 
associated with the results that were shown. The team also needs to consider all of the 
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scores when evaluating the results in reference to gender due to evidence that shows 
males are less likely to report mental health concerns.  
There is also evidence that shows significant differences between age and gender 
when it comes to mental health. A study surveyed school-aged 11 and conducted a post-
test at age 15. Of the population surveyed at 11 years of age, 33 percent of males and 37 
percent of the females reported feeling sad, unhappy, or low in the month before the 
survey was distributed (Johansson et al., 2007). There is a gap in the literature that 
suggests why this occurs. As previously mentioned, studies provide the explanation that 
females are more open to reporting their mental health symptoms compared to males. 
Therefore, the findings from these studies and reviews could suggest why the females in 
our study possessed higher depressive symptoms. It could be attributed to the willingness 
of the females to be open about how they were feeling. A topic of importance is the 
difficulty of the subject. The Johansson and colleagues’ study that found that 13-year-old 
adolescents had more of a challenge understanding the concept of mental health 
compared to the 16-year-olds (Johansson et al., 2007). 
In addition to openness, research found that girls are more likely to be 
knowledgeable of mental health and more expressive of the problems they face 
(Johansson et al., 2007). Adolescents fear that opening up and talking about their mental 
health problems will lead them to be treated as an outcast among their peers (Johansson 
et al., 2007). However, Johansson’s study confirmed that girls are more comfortable 
talking about how they are feeling (Johansson et al., 2007). This could suggest why our 
study’s findings show a significant increase in the PHQ-9 scores among the females.  
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However, there is still an important question to answer. If females have higher 
scores of depressive symptoms, then why is there no significance in the length of stay or 
hospitalizations related to gender? A study concluded that patients diagnosed with a 
mental health disorder did not necessarily have differing adherence rates than their peers 
who were not diagnosed with a disorder (White et al., 2009). This could explain why 
there was no correlation between mental health symptoms and hospitalizations. It is 
hypothesized that if adherence rates increase then hospitalizations. It is hypothesized that 
is adherence rates increase then hospitalizations should decrease. There was also limited 
data that could be used for this study, therefore; the sample size may not have been large 
enough to see a significant relationship between mental health symptoms and 
hospitalizations. 
Overall, this study possessed a variety of strengths. First, the screenings have 
proven to possess high reliability and validity. There was a high response rate with the 
patients who chose to complete the self-report screenings. Finally, the results are 
consistent with the literature when considering depressive symptoms related to gender. 
However, there are important limitations to note as well.  
Limitations 
There are a number of limitations to note when considering this study. First, the 
study used existing data within the Children’s Health CF Clinic’s shared drive. This data 
only contains results from 2016 therefore; this study could only use data from one year. 
Second, the data was limited because it only contains age, gender, PHQ-9, and GAD-7 
screening scores. Our demographic information was limited. Therefore, there were 
limited factors that could be analyzed. Third, time constraints restricted this study from 
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pursuing other variables that could have been used for this study such as primary payer 
status, disease severity, ethnicity, and region. Lastly, the instruments used are self-
reported, which could be a limitation in itself. The difficulty of the subject matter and 
how the child was feeling the day of the screening could have an effect on the reports 
they chose. 
Future Implications 
When the CF Foundation established the guidelines that all adolescents aged 12 
years old and above needed to be screened for mental health symptoms; their goal was to 
decrease the risk for depression and anxiety. This study’s findings can suggest 
implications for this risk to future clinical teams, parents and caregivers, and peers of 
adolescents with CF. Although the findings suggest females have a higher rate of 
reporting depressive symptoms, attention needs to be given to all patients that score 
moderate to severe symptoms. This study’s findings show that there is a great need for 
mental health resources among the adolescent population. It is also an indicator to the 
medical staff on who needs to be given priority to be seen first. This data could be used 
for quality improvement among specialized CF centers across the world. Incorporating 
mental health care into the CF center could potentially increase the children’s overall 
quality of life.  
Being sensitive to the concerns and providing resources can enhance the quality 
of care given to the patients. They cannot continue to get physically well if their mental 
health state is not being addressed. Furthermore, these findings can help with the 
transition to adult care because they provide the medical staff with considerations of 
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where to transition their patients. It is important to note that metal health concerns should 
be considered a priority when caring for patients with CF. 
There is an opportunity for further research utilizing data that has been collected 
since the development of this study. This research may pose opportunities for further 
research on why adolescent females are more willing to report their mental health 
concerns compared to their male counterparts. This translates to the need for developing 
interventions to address the male population on this issue. Incorporating peer support 
groups could potentially make the adolescents feel more comfortable talking about their 
mental health status. However, it is important to note that CF patients cannot be in close 
proximity to each other due to infection control policies. Therefore, peer support groups 
may need to be through an external source such as social media or a video chat group. 
Useful information may be gleaned from screening parents in the future. The CF 
guidelines suggest screening parents for depression and anxiety symptoms in addition to 
the adolescents. Because parents have a strong impact on their children, their mental 
health status may need to be monitored in order to address any concerns that they may 
have. The sample size could be increased and the data being utilized could be over a 
larger span of time. This is an ongoing data collection process, which means the 
screenings that were administered after this study was complete could be used to develop 
a modification to this study or an additional study in the future.  
Conclusion 
In conclusion, this study was conducted to determine if mental health status had 
an effect on overall health. The findings of this study can potentially help contribute to 
addressing the mental health concerns among the adolescent population who are living 
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with CF. Existing literature is in line with this study in regards to mental health and 
gender. Therefore, more research needs to be conducted when discussing how to talk to 
females and males regarding their mental health.  
A chronic illness such as CF has a major impact on the patient and caregivers. 
More attention needs to be given to families and caregivers who are working with 
adolescents that have CF. High levels of depression and anxiety exist among the family 
as well. Therefore, the team needs to address all of these concerns before making any 
changes to the treatment regimen. 
The medical team can use this research to make evidence-informed decisions in 
regards to mental health status of adolescents. This study can potentially increase the 
literature on mental health related to adolescents and their overall quality of life. By 
continuing this study, the clinic can find more trends and results, which will lead to 
improving the mental health care provided by the CF center.  
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APPENDIX C 
Patient Health Questionnaire (PHQ-9)
 
 
P A T I E N T  H E A L T H  Q U E S T I O N N A I R E - 9   
( P H Q - 9 )  
Over the last 2 weeks, how often have you been bothered 
by any of the following problems? 
(Use “✔” to indicate your answer) Not at all 
Several 
days 
More 
than half 
the days 
Nearly 
every 
day 
1. Little interest or pleasure in doing things 0 1 2 3 
2. Feeling down, depressed, or hopeless 0 1 2 3 
3. Trouble falling or staying asleep, or sleeping too much 0 1 2 3 
4. Feeling tired or having little energy 0 1 2 3 
5. Poor appetite or overeating 0 1 2 3 
6. Feeling bad about yourself — or that you are a failure or 
have let yourself or your family down 0 1 2 3 
7. Trouble concentrating on things, such as reading the 
newspaper or watching television 0 1 2 3 
8. Moving or speaking so slowly that other people could have 
noticed?  Or the opposite — being so fidgety or restless 
that you have been moving around a lot more than usual 
0 1 2 3 
9. Thoughts that you would be better off dead or of hurting 
yourself in some way 0 1 2 3 
                                                                                                              FOR OFFICE CODING     0      + ______  +  ______  +  ______ 
=Total Score:  ______ 
 
     
If you checked off any problems, how difficult have these problems made it for you to do your 
work, take care of things at home, or get along with other people? 
Not difficult  
at all 
 
Somewhat  
difficult 
 
Very  
difficult 
 
Extremely  
difficult 
 
 
 
 
 
 
 
 
 
 
Developed by Drs. Robert L. Spitzer, Janet B.W. Williams, Kurt Kroenke and colleagues, with an educational grant from 
Pfizer Inc.  No permission required to reproduce, translate, display or distribute. 
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APPENDIX D 
Generalized Anxiety Disorder 7-Item Scale (GAD-7)
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